Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway

<div>Expression data of COX2 at the single cell level of hepatocellular carcinoma. (a, b) The expression of COX2 in single liver cell. (c) The expression of COX2 in a single HCC cell.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway 